Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,842 | -3,590 | -10,122 | -7,407 | -4,829 |
| Depreciation Amortization | 340 | 73 | 211 | 164 | 76 |
| Accounts receivable | -53 | N/A | 231 | N/A | 177 |
| Other Working Capital | -697 | -133 | -178 | 95 | -487 |
| Other Operating Activity | 4,380 | 1,137 | 1,380 | 1,188 | 524 |
| Operating Cash Flow | $-5,872 | $-2,513 | $-8,478 | $-5,959 | $-4,539 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -2 | -39 | -30 | -30 |
| Other Investing Activity | -232 | -95 | -216 | -158 | -120 |
| Investing Cash Flow | $-238 | $-97 | $-255 | $-188 | $-150 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,551 | 7,551 | N/A | N/A | N/A |
| Debt Repayment | N/A | -49 | N/A | -16 | N/A |
| Common Stock Issued | 2,397 | 323 | 13,889 | 13,685 | 4,877 |
| Other Financing Activity | -116 | 0 | -65 | 0 | 0 |
| Financing Cash Flow | $9,832 | $7,825 | $13,824 | $13,669 | $4,877 |
| Beginning Cash Position | 7,444 | 7,444 | 2,352 | 2,352 | 2,352 |
| End Cash Position | 11,166 | 12,659 | 7,444 | 9,873 | 2,540 |
| Net Cash Flow | $3,722 | $5,216 | $5,092 | $7,521 | $188 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,872 | -2,513 | -8,478 | -5,959 | -4,539 |
| Capital Expenditure | -5 | -2 | -39 | -30 | -30 |
| Free Cash Flow | -5,878 | -2,514 | -8,517 | -5,990 | -4,569 |